I E Smith

4.6k total citations · 1 hit paper
59 papers, 3.5k citations indexed

About

I E Smith is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, I E Smith has authored 59 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Genetics and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in I E Smith's work include Estrogen and related hormone effects (18 papers), Breast Cancer Treatment Studies (12 papers) and Cancer Treatment and Pharmacology (9 papers). I E Smith is often cited by papers focused on Estrogen and related hormone effects (18 papers), Breast Cancer Treatment Studies (12 papers) and Cancer Treatment and Pharmacology (9 papers). I E Smith collaborates with scholars based in United Kingdom, United States and Canada. I E Smith's co-authors include Mitch Dowsett, R. Charles Coombes, Torsten O. Nielsen, Mathew J. Ellis, Tracy Lively, Seungmok Paik, Janine Salter, Christos Sotiriou, Daniel F. Hayes and N. Lynn Henry and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

I E Smith

58 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

2011 1.5k citations R. Charles Coombes, I E Smith et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I E Smith United Kingdom	23	1.8k	1.5k	1.1k	777	657	59	3.5k
Mark L. Graham United States	26	2.2k 1.2×	1.7k 1.1×	1.1k 1.0×	1.3k 1.6×	574 0.9×	53	4.5k
T.J. Powles United Kingdom	34	1.9k 1.0×	1.2k 0.8×	1.1k 1.0×	777 1.0×	505 0.8×	73	3.7k
Thomas Hatschek Sweden	29	2.4k 1.3×	1.9k 1.2×	754 0.7×	1.1k 1.5×	956 1.5×	100	4.5k
K Holli Finland	28	1.8k 1.0×	1.3k 0.9×	772 0.7×	778 1.0×	380 0.6×	47	3.0k
J Cuzick United Kingdom	7	2.0k 1.1×	2.0k 1.3×	1.6k 1.5×	565 0.7×	561 0.9×	10	3.6k
Angelo Raffaele Bianco Italy	34	2.6k 1.4×	860 0.6×	574 0.5×	1.4k 1.8×	987 1.5×	100	4.2k
D C Tormey United States	32	2.1k 1.2×	1.1k 0.7×	644 0.6×	561 0.7×	718 1.1×	55	3.6k
C. Kent Osborne United States	33	2.9k 1.6×	2.1k 1.4×	1.8k 1.6×	2.2k 2.8×	743 1.1×	82	5.6k
John F. R. Robertson United Kingdom	25	1.3k 0.7×	803 0.5×	807 0.7×	882 1.1×	564 0.9×	52	2.7k
Rosalba Torrisi Italy	35	2.4k 1.3×	1.9k 1.2×	724 0.6×	1.0k 1.3×	671 1.0×	130	4.2k

Countries citing papers authored by I E Smith

Since Specialization

Citations

This map shows the geographic impact of I E Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I E Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I E Smith more than expected).

Fields of papers citing papers by I E Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I E Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I E Smith. The network helps show where I E Smith may publish in the future.

Co-authorship network of co-authors of I E Smith

This figure shows the co-authorship network connecting the top 25 collaborators of I E Smith. A scholar is included among the top collaborators of I E Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I E Smith. I E Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nolte, Ellen, Fred Martineau, Michelle A. Miller, et al.. (2025). Barriers and facilitators to specialist service referrals for sleep disorders from healthcare professionals’ perspective: A scoping review of qualitative research evidence. medRxiv. 1 indexed citations

Davies, M.G., et al.. (2017). Hospital outcomes and long-term survival after referral to a specialized weaning unit. British Journal of Anaesthesia. 118(4). 563–569. 22 indexed citations

Turner, Nicholas C., I E Smith, E O’Brien, et al.. (2016). Central nervous system (CNS) disease during trastuzumab emtansine (T-DM1) for HER2 positive advanced breast cancer (ABC): A single institution experience. Annals of Oncology. 27. vi83–vi83. 1 indexed citations

Highcock, Martin, et al.. (2002). An overnight comparison of two ventilators used in the treatment of chronic respiratory failure. European Respiratory Journal. 20(4). 942–945. 17 indexed citations

Leyland‐Jones, Brian & I E Smith. (2001). Role of Herceptin<sup>®</sup> in Primary Breast Cancer: Views from North America and Europe. Oncology. 61(Suppl. 2). 83–91. 17 indexed citations

Dowsett, Mitch, C. Pfister, D.W. Miles, et al.. (1999). Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer.. PubMed. 5(9). 2338–43. 70 indexed citations

Smith, I E. (1999). Aromatase inhibitors: a dose-response effect?. Endocrine Related Cancer. 6(2). 245–249. 21 indexed citations

Gwyther, Stephen J., et al.. (1999). Results of an independent oncology review board of pivotal clinical trials of gemcitabine in non-small cell lung cancer. Anti-Cancer Drugs. 10(8). 693–698. 17 indexed citations

Newby, Jacqueline C., Stephen Johnston, I E Smith, & Mitch Dowsett. (1997). Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer.. PubMed. 3(9). 1643–51. 156 indexed citations

10.

Nicolson, MC, et al.. (1997). Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy. British Journal of Cancer. 76(12). 1636–1639. 20 indexed citations

11.

Cunningham, David, John Zalcberg, I E Smith, et al.. (1996). ‘Tomudex’ (ZD1694) : A novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. Annals of Oncology. 7(2). 179–182. 45 indexed citations

12.

Smith, I E, et al.. (1996). Kyphosis Secondary to Tuberculosis Osteomyelitis as a Cause of Ventilatory Failure. CHEST Journal. 110(4). 1105–1110. 15 indexed citations

13.

Smyth, J F, I E Smith, C. Sessa, et al.. (1994). Activity of docetaxel (Taxotere) in small cell lung cancer. European Journal of Cancer. 30(8). 1058–1060. 105 indexed citations

14.

Dowsett, Mitch, John W. Moore, P Trunet, et al.. (1994). Endocrine changes with the aromatase inhibitor fadrozole hydrochloride in breast cancer. European Journal of Cancer. 30(10). 1453–1458. 36 indexed citations

15.

Jackson, Matthew J., I E Smith, M. T. King, & John M. Shneerson. (1994). Long term non-invasive domiciliary assisted ventilation for respiratory failure following thoracoplasty.. Thorax. 49(9). 915–919. 24 indexed citations

16.

Hickish, Tamas, David Cunningham, Janine Mansi, et al.. (1993). EPIC: an effective low toxicity regimen for relapsing lymphoma. British Journal of Cancer. 68(3). 599–604. 19 indexed citations

17.

Boyle, P J, Angelo Avogaro, I E Smith, et al.. (1992). Absence of the dawn phenomenon and abnormal lipolysis in Type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency. Diabetologia. 35(4). 372–379. 23 indexed citations

18.

Talbot, D C & I E Smith. (1992). New perspectives in lung cancer.5. New drugs in lung cancer.. Thorax. 47(3). 188–194. 4 indexed citations

19.

Cairnduff, F., et al.. (1987). High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer. European Journal of Cancer and Clinical Oncology. 23(12). 1895–1900. 32 indexed citations

20.

Harris, Adrian L., Mitch Dowsett, S.L. Jeffcoate, & I E Smith. (1982). The site of action of amino-glutethimide (AG) in advanced breast cancer. British Journal of Cancer. 46(3). 496–497. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact